ORCHARD- Optimising Home Assessment of Rural Patients (ORCHARD)

Inclusion Criteria: ● Solid organ transplant recipient On the COVID-19 shielding list People with specific cancers People with cancer who had chemotherapy within the last 2 years People with lung cancer that have had radical radiotherapy within the last two years People with cancer of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at end stage treatment People that have had immunotherapy or other continuing antibody treatments for cancer within the last two years People that had other targeted cancer treatment which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors within the last two years People who had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs People with severe respiratory conditions including all cystic fibrosis, severe asthma, and severe COPD People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell anaemia) People in immunosuppression therapies sufficient to significantly increase risk of infection Inclusion criteria for GPs: A GP working at the pilot study practice and carried out telemedicine consultations with participants A GP who can provide informed consent Exclusion Criteria: People whose GP feels they are not able to participate in the research. People unable to consent to participate. Non-English speakers Exclusion criteria for GPs: A GP that cannot provide informed consent